DarioHealth Corp. logo

DarioHealth Corp.

DRIO | NASDAQ
Chart Builder DCF Calculator
$7.07
-$0.13 (-1.81%)
At close: Sep 21, 2026, 4:00 PM ET
$6.95
-$0.12 (-1.70%)
After-hours: Sep 21, 2026, 4:27 PM ET

Company Profile

DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.

Key Executives

Name Position
Erez Raphael Chief Executive Officer & Director
Chen Franco-Yehuda Chief Financial Officer, Treasurer & Secretary
Claudia Levi Content & Communications Manager
Dov Oppenheim Co-Founder & Production Chief
Kat Parrella Investor Relations Manager
Lara Dodo Chief Operations Officer
Mona Dean Chief Compliance Officer
Omar Manejwala Chief Medical Officer
Rob Halpern SVP of Marketing
Steven C. Nelson President & Chief Commercial Officer (Leave of Absence)
Zoe Harrison VP of Accounting & Corporate Development

Latest SEC Filings

Date Type Title
Sep 04, 2026 8-K Current Report
Aug 21, 2026 8-K Current Report
Aug 11, 2026 10-Q Quarterly Report
Jul 28, 2026 4 Filing
Jul 22, 2026 8-K Current Report
Jul 22, 2026 424B5 Filing
Jul 10, 2026 8-K Current Report
May 13, 2026 10-Q Quarterly Report
May 07, 2026 SD Filing
Apr 13, 2026 3 Filing
View All SEC Filings
DarioHealth Corp.
DarioHealth Corp. logo
Country United States
IPO Date Mar 13, 2016
Industry Medical - Specialties
Sector Healthcare
Employees 163
CEO Erez Raphael

Contact Details

322 W. 57th Street New York City, New York 10019 United States

Stock Details

Ticker Symbol DRIO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001533998
CUSIP Number 23725P308
ISIN Number US23725P3082
SIC Code 3841

© 2026 bestshares.com. All rights reserved.